Skip to main navigation Skip to search Skip to main content

Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey

  • Eva W. H. Korte
  • , Marjolein A. J. Hiel
  • , Maria C. Bolling
  • , Patrick Dunn
  • , D. dée F. Murrell
  • , Victoria P. Werth
  • , Marc Yale
  • , Phyllis I. Spuls
  • , Joost M. Meijer
  • , Barbara Horváth
  • University of Groningen
  • International Pemphigus and Pemphigoid Foundation
  • University of New South Wales
  • VA Medical Center
  • University of Pennsylvania
  • University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

35 Downloads (Pure)

Abstract

This study analysed 32 failed drug development trials and surveyed 56 experts in the field of autoimmune bullous diseases to identify key challenges in bullous pemphigoid and pemphigus research. Clinical trials primarily failed due to unmet efficacy endpoints and recruitment difficulties, with experts highlighting the need to improve endpoint selection and patient enrolment strategies through international collaboration to develop more effective trial designs and advance new therapeutic options.

Original languageEnglish
Pages (from-to)165-167
Number of pages3
JournalBritish journal of dermatology
Volume194
Issue number1
DOIs
Publication statusPublished - 1 Jan 2026

Fingerprint

Dive into the research topics of 'Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey'. Together they form a unique fingerprint.

Cite this